IMPURITIES AVAILABLE FOR 'Abemaciclib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Abemaciclib. Abemaciclib is a small-molecule anticancer drug classified as a cyclin-dependent kinase (CDK) 4 and 6 inhibitor. It works by blocking CDK4/6 activity, which prevents phosphorylation of the retinoblastoma protein and halts cell-cycle progression. This action leads to inhibition of tumor cell proliferation, particularly in hormone receptor–positive breast cancer. Abemaciclib is administered orally and is available in tablet form. It is mainly indicated for the treatment of advanced or metastatic breast cancer. The drug appears as a yellow to orange solid powder. Common side effects include diarrhea, fatigue, neutropenia, and nausea. Abemaciclib is often used alone or in combination with endocrine therapy. Buy high quality Abemaciclib from Omsynth Lifesciences.